Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 168

1.

Comorbidities, metabolic risk profile and health-related quality of life in German patients with plaque-type psoriasis: a cross-sectional prospective study.

Jacobi A, Kupke C, Behzad M, Hertl M.

Int J Dermatol. 2013 Sep;52(9):1081-7. doi: 10.1111/j.1365-4632.2012.05517.x. Epub 2013 Feb 22.

PMID:
23432542
2.

Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter cross-sectional study in Germany.

Augustin M, Krüger K, Radtke MA, Schwippl I, Reich K.

Dermatology. 2008;216(4):366-72. doi: 10.1159/000119415. Epub 2008 Mar 4.

PMID:
18319601
3.

Comorbidities and cardiovascular risk factors in patients with psoriasis.

Baeta IG, Bittencourt FV, Gontijo B, Goulart EM.

An Bras Dermatol. 2014 Sep-Oct;89(5):735-44.

4.

Psoriasis and comorbidities in a southern Brazilian population: a case-control study.

Menegon DB, Pereira AG, Camerin AC, Cestari T.

Int J Dermatol. 2014 Nov;53(11):e518-25. doi: 10.1111/ijd.12186. Epub 2014 Jul 29.

PMID:
25070669
5.

Quality of life and related factors in a cohort of plaque-type psoriasis patients in La Coruña, Spain.

Fernández-Torres RM, Pita-Fernández S, Fonseca E.

Int J Dermatol. 2014 Nov;53(11):e507-11. doi: 10.1111/ijd.12294. Epub 2014 Sep 30.

PMID:
25266080
6.

Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases.

Phan C, Sigal ML, Lhafa M, Barthélémy H, Maccari F, Estève E, Reguiai Z, Perrot JL, Chaby G, Maillard H, Bégon E, Alexandre M, Toussaint P, Bastien-Jacquin M, Bravard P, Sauque E, de Quatrebarbes J, Pfister P, Beauchet A, Mahé E; GEM Resopso.

Ann Dermatol Venereol. 2016 Apr;143(4):264-74. doi: 10.1016/j.annder.2015.06.024. Epub 2016 Mar 8.

PMID:
26969480
7.

Comorbidities and health-related quality of life in Spanish patients with moderate to severe psoriasis: a cross-sectional study (Arizona study).

Sanchez-Carazo JL, López-Estebaranz JL, Guisado C.

J Dermatol. 2014 Aug;41(8):673-8. doi: 10.1111/1346-8138.12465. Epub 2014 Jun 18.

PMID:
24942203
8.

Psoriasis in patients older than 65 years. A comparative study with younger adult psoriatic patients.

Fernandez-Torres RM, Paradela S, Fonseca E.

J Nutr Health Aging. 2012;16(6):586-91.

PMID:
22660002
9.

Cardiovascular risk factors and cardiovascular diseases in patients with moderate to severe psoriasis under systemic treatment. PSO-RISK, descriptive study.

Vanaclocha F, Belinchón I, Sánchez-Carazo JL, Rivera R, Carrascosa JM, Cea-Calvo L, Juliá B, Puig L.

Eur J Dermatol. 2014 Nov-Dec;24(6):662-9. doi: 10.1684/ejd.2014.2440.

PMID:
25333326
10.

Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis.

Reich K, Krüger K, Mössner R, Augustin M.

Br J Dermatol. 2009 May;160(5):1040-7. doi: 10.1111/j.1365-2133.2008.09023.x. Epub 2009 Feb 4.

PMID:
19210498
11.

Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study.

Mahé E, Reguiai Z, Barthelemy H, Quiles-Tsimaratos N, Chaby G, Girard C, Estève E, Maccari F, Descamps V, Schmutz JL, Begon E, Bravard P, Maillard H, Boyé T, Beauchet A, Sigal ML; GEM Resopso.

J Eur Acad Dermatol Venereol. 2014 Feb;28(2):151-9. doi: 10.1111/jdv.12066. Epub 2012 Dec 28.

PMID:
23279264
12.

Costs and quality of life in patients with moderate to severe plaque-type psoriasis in Germany: a multi-center study.

Schöffski O, Augustin M, Prinz J, Rauner K, Schubert E, Sohn S, Reich K.

J Dtsch Dermatol Ges. 2007 Mar;5(3):209-18. English, German.

PMID:
17338796
13.

Psoriasis: cardiovascular risk factors and other disease comorbidities.

Wu Y, Mills D, Bala M.

J Drugs Dermatol. 2008 Apr;7(4):373-7.

PMID:
18459519
14.

Diagnosis and underdiagnosis of comorbidities in psoriasis patients - need for a multidisciplinary approach.

Duarte GV, Oliveira MF, Follador I, Silva TS, Carvalho EM Filho.

An Bras Dermatol. 2016 Nov-Dec;91(6):743-747. doi: 10.1590/abd1806-4841.20164716.

15.

[Cardiovascular risk profile of patients with psoriasis].

Di Lisi D, Macaione F, Corrado E, Bonura F, Novo G, Peritore A, Meschisi M, Cuttitta F, Bongiorno MR, Novo S.

Recenti Prog Med. 2013 Mar;104(3):102-5. doi: 10.1701/1255.13857. Italian.

PMID:
23548953
16.

Comorbidities significantly impact patients' preferences for psoriasis treatments.

Schmieder A, Schaarschmidt ML, Umar N, Terris DD, Goebeler M, Goerdt S, Peitsch WK.

J Am Acad Dermatol. 2012 Sep;67(3):363-72. doi: 10.1016/j.jaad.2011.08.023. Epub 2011 Oct 19.

PMID:
22015150
17.

Epidemiology and quality of life of patients with psoriasis in Chile.

Valenzuela F, Silva P, Valdés MP, Papp K.

Actas Dermosifiliogr. 2011 Dec;102(10):810-6. doi: 10.1016/j.ad.2011.03.022. Epub 2011 Jun 12.

PMID:
21664589
18.

Psoriasis and cardiovascular screening rates in the United States.

Alamdari HS, Gustafson CJ, Davis SA, Huang W, Feldman SR.

J Drugs Dermatol. 2013 Jan;12(1):e14-9.

PMID:
23377342
19.

Comorbidities associated with psoriasis: an experience from the Middle East.

Al-Mutairi N, Al-Farag S, Al-Mutairi A, Al-Shiltawy M.

J Dermatol. 2010 Feb;37(2):146-55. doi: 10.1111/j.1346-8138.2009.00777.x.

PMID:
20175849
20.

Cardiovascular and metabolic risk profile in German patients with moderate and severe psoriasis: a case control study.

Warnecke C, Manousaridis I, Herr R, Terris DD, Goebeler M, Goerdt S, Peitsch WK.

Eur J Dermatol. 2011 Sep-Oct;21(5):761-70. doi: 10.1684/ejd.2011.1467.

PMID:
21737374

Supplemental Content

Support Center